Inventor · disambiguated record
Izabela Fokt
Also filed as: FOKT IZABELA
23 granted patents·7 pending applications·202 citations·filing 1997–2022
95Inventor score
Top patents by PatentIndex Score
30 records- 0194US8143412B2Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)PRIEBE WALDEMAR·Filed 2009·Granted Mar 27, 2012·27 cites·9 claims
- 0290US8252740B2Thermally-targeted delivery of medicaments including doxorubicinRAUCHER DRAZEN·Filed 2007·Granted Aug 28, 2012·15 cites·14 claims
- 0388US8299033B2Iodo-hexose compounds useful to treat cancerPRIEBE WALDEMAR·Filed 2009·Granted Oct 30, 2012·14 cites·7 claims
- 0485US5874412ABis-anthracyclines with high activity against doxorubicin resistant tumorsFiled 1997·Granted Feb 23, 1999·97 cites·25 claims
- 0581US7745468B2Compounds for treatment of cell proliferative diseasesUNIV TEXAS·Filed 2004·Granted Jun 29, 2010·12 cites·23 claims
- 0680US8927506B2Acetates of 2-deoxy monosaccharides with anticancer activityPRIEBE WALDEMAR·Filed 2009·Granted Jan 6, 2015·5 cites·8 claims
- 0776US11026960B2Esters of 2-deoxy-monosaccharides with anti proliferative activityUNIV TEXAS·Filed 2018·Granted Jun 8, 2021·1 cites·5 claims
- 0876US10201554B2Esters of 2-deoxy-monosacharides with anti proliferative activityUNIV TEXAS·Filed 2014·Granted Feb 12, 2019·2 cites·8 claims
- 0975US9149489B2Inhibitors of glycolysis useful in the treatment of brain tumorsPRIEBE WALDEMAN·Filed 2009·Granted Oct 6, 2015·3 cites·1 claims
- 1075US8779151B2Orally bioavailable caffeic acid related anticancer drugsPRIEBE WALDEMAR·Filed 2007·Granted Jul 15, 2014·2 cites·27 claims
- 1172US11925654B2Esters of 2-deoxy-monosaccharides with anti proliferative activityUNIV TEXAS·Filed 2021·Granted Mar 12, 2024·0 cites·32 claims
- 1272US9096499B2Compounds for treatment of cell proliferative diseasesUNIV TEXAS·Filed 2014·Granted Aug 4, 2015·1 cites·10 claims
- 1372US9000179B2Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)UNIV TEXAS·Filed 2013·Granted Apr 7, 2015·1 cites·6 claims
- 1471US8648102B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2012·Granted Feb 11, 2014·1 cites·12 claims
- 1571US8119827B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2010·Granted Feb 21, 2012·1 cites·16 claims
- 1670US8637675B2Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)PRIEBE WALDEMAR·Filed 2012·Granted Jan 28, 2014·1 cites·16 claims
- 1767US10703721B2Caffeic acid derivatives and uses thereofUNIV TEXAS·Filed 2018·Granted Jul 7, 2020·1 cites·21 claims
- 1865US7365096B2Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)UNIV TEXAS·Filed 2003·Granted Apr 29, 2008·3 cites·40 claims
- 1964US7928062B2Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)UNIV TEXAS·Filed 2007·Granted Apr 19, 2011·0 cites·11 claims
- 2064US6680300B2Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agentsUNIV TEXAS·Filed 2002·Granted Jan 20, 2004·1 cites·19 claims
- 2159US6437105B1Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agentsUNIV TEXAS·Filed 1999·Granted Aug 20, 2002·11 cites·15 claims
- 2257US2025009727A1Water-soluble salts of dna binding agentsUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2356US2022347168A1Lung targeted anticancer therapies with liposomal annamycinUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2454US2010130434A1Hexose Compounds to Treat CancerUNIV TEXAS·Filed 2007·Application pending·0 cites
- 2552US2023130134A1Method of treating viral infections with hexose type monosaccharides and analogs thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2651US2015094343A1Orally bioavailable caffeic acid related anticancer drugsUNIV TEXAS·Filed 2014·Application pending·0 cites
- 2745US2010144802A1Small Molecule Inhibitors for Immune ModulationHEIMBERGER AMY B·Filed 2008·Application pending·0 cites
- 2844US10358439B2DNA binding agents with a minor groove binding tailUNIV TEXAS·Filed 2016·Granted Jul 23, 2019·0 cites·20 claims
- 2936US6355784B1Methods and compositions for the manufacture of halogenated anthracyclines with increased antitumor activity, other anthracyclines, halogenated sugars, and glycosyl donorsFiled 1999·Granted Mar 12, 2002·3 cites·7 claims
- 3035US2013129675A1Interferon therapies in combination with blockade of stat3 activationPRIEBE WALDEMAR·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Izabela Fokt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →